Syncom Formulations (India) logo

Syncom Formulations (India) Q1 results, quarter to Jun 2026

NSE: SYNCOMFBSE: 524470Pharmaceuticals & BiotechnologySmall Cap

Syncom Formulations (India) Limited · Face value ₹1 · Listed Apr 1994 on BSE, Nov 2022 on NSE
Last close ₹19.24down ₹1.17 (5.73%)BSE ₹19.25

Share price at the NSE close on 30 Oct 2026. Previous close ₹20.41.

30 Oct: open ₹20.41, high ₹20.41, low ₹19.01

52-week range of traded prices to 30 Oct 2026
₹10.21Low, 30 Mar 2026₹27.49High, 30 Sep 2026
Market cap
₹1,809 Cr1,369th largest listed
P/E
21.15
P/B
4.36
Dividend yield
0.52%
ROE
22.6%
ROCE
19.5%
Debt to equity
0.00
Volume, NSE
83,30,70341.3% delivered

Syncom Formulations (India) filed its Q1 results for the quarter to Jun 2026 on 11 Aug 2026 at 6:53 pm, standalone: the listed company alone, without its subsidiaries.

Q1 results, quarter to Jun 2026

₹ crore.Syncom Formulations (India) annual results and balance sheet

Revenue
₹125 Cr+7.0% on a year ago · −7.0% on the quarter before
Operating profit
₹26 Cr+63.9% on a year ago · +20.4% on the quarter before
Net profit
₹25 Cr+56.3% on a year ago · +0.1% on the quarter before
Earnings per share
₹0.26+23.8% on a year ago · 0.0% on the quarter before
Operating margin
20.7%
Net margin
19.7%

From revenue to net profit, ₹ crore

  1. Revenue125
  2. Materials and goods−66
  3. Employee costs−17
  4. Other expenses−16
  5. Operating profit26
  6. Depreciation−1.5
  7. Other income+7.8
  8. Finance costs−0.2
  9. Profit before tax32
  10. Tax−7.3
  11. Net profit25

Syncom Formulations (India) results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
626.2Sep 23636.4Dec 23736.7Mar 24867.6Jun 2410111Sep 2412713Dec 2414818Mar 2511716Jun 2512117Sep 2511519Dec 2513425Mar 2612525Jun 26
Peak revenue ₹148 Cr, quarter to Mar 2025; lowest ₹62 Cr, quarter to Sep 2023

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
20.7%8.9%9.8%10.7%12.0%11.1%11.8%11.5%11.8%13.5%15.4%18.5%16.0%20.7%9.9%10.1%9.2%8.9%10.8%10.1%11.8%13.5%13.9%16.5%18.3%19.7%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Jun 26
₹ croreSep 2021Dec 2021Q3Mar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Jun 2023Q1Filed 14 AugSep 2023Dec 2023Q3Mar 2024Jun 2024Q1Sep 2024Dec 2024Q3Mar 2025Q4Jun 2025Q1Sep 2025Q2Filed 12 NovDec 2025Q3Filed 12 FebMar 2026Q4Filed 22 MayJun 2026Q1
Revenue from operations535758515457615962637386101127148117121115134125
475256485051555356576476901121311011039311399
Materials and goods bought32383733363538363839435466871006971618366
Employee costs566567789109111214151617171717
Other expenses10813107910109813111212161615151316
Operating profit before depreciation65234666679101215171619212126
Operating margin10.7%8.6%3.3%6.8%7.9%10.3%9.7%10.4%9.8%10.7%12.0%11.1%11.8%11.5%11.8%13.5%15.4%18.5%16.0%20.7%
Depreciation and amortisation11111111111111111122
Other income326332724432447655148
Finance costs00111111111000000000
Profit before one-off items and tax766556106899101517232022253332
One-off items00000000000000000000
Profit before tax766556106899101517232022253332
22112222222244656687
Tax rate23.0%33.0%16.3%22.1%33.0%30.5%17.6%26.9%23.8%25.3%26.7%24.4%25.2%24.3%23.9%22.4%24.7%24.7%25.2%22.9%
Net profit6454448466781113181617192525
Other comprehensive income02−1−11102122340−2402−104
Total comprehensive income56435596788101513152017211528
Net margin10.6%7.0%8.2%7.5%6.6%7.2%13.8%7.2%9.9%10.1%9.2%8.9%10.8%10.1%11.8%13.5%13.9%16.5%18.3%19.7%
Earnings per share₹0.06₹0.07₹0.05₹0.03₹0.06₹0.06₹0.10₹0.07₹0.08₹0.09₹0.09–₹0.16₹0.14₹0.16₹0.21₹0.18₹0.23₹0.26₹0.26
Diluted earnings per share₹0.06₹0.06₹0.05₹0.03₹0.06₹0.06₹0.10₹0.07₹0.08₹0.09₹0.09–₹0.16₹0.14₹0.16₹0.21₹0.18₹0.23₹0.26₹0.26
Earnings per share in rupees, restated for later splits and bonuses.

The quarter to Jun 2024 was restated in the company's filing of 12 Nov 2024. The table shows the restated figures.